Nucleosides

Fluorescein-5(6)-carboxamidocaproyl-[5(3-aminoallyl)2-deoxyuridine-5-triphosphate] is a modified nucleoside analog that is used as an antiviral agent against herpesviruses. This compound is phosphorylated by the virus encoded thymidine kinase, which converts it to the monophosphate form. Fluorescein-5(6)-carboxamidocaproyl-[5(3-aminoallyl)2-deoxyuridine-5-triphosphate] inhibits DNA synthesis by inhibiting viral DNA polymerase and has been shown to be active against human papillomavirus type 16 (HPV16) in vitro. It has also been shown to inhibit tumor cell proliferation and induce apoptosis in some types of cancer cells.

9-(2',3',5'-Tri-O-benzoyl-b-D-ribofuranosyl)-2-chloropurine is a modified nucleoside with anticancer activity. It has been shown to be an effective activator of DNA, RNA, and protein synthesis in vitro. This drug has also been shown to have antiviral properties against herpes simplex virus type 1 (HSV1) and influenza A virus. 9-(2',3',5'-Tri-O-benzoyl-b-D-ribofuranosyl)-2-chloropurine is an analog of the natural purine metabolite hypoxanthine that can be synthesized in high purity.

5'-O-DMT-N2-phenoxyacetyl-2'-O-methylguanosine 3'-CE phosphoramidite is a nucleoside analog that inhibits DNA synthesis by forming a covalent bond with the beta-subunit of DNA polymerase. It is a modified nucleoside that has been synthesized from 2'-O-methylguanosine and N2,N2-dimethoxyacetyl. 5'-O-DMT-N2-phenoxyacetyl-2'-O methylguanosine 3'-CE phosphoramidite possesses the CAS No. 16053526.

N4-Benzoyl-5'-O-DMT-(2'-O, 4'-C-methylene)-5-methyl-a-cytidine 3'-CE phosphoramidite is a novel modified nucleoside that has antiviral and anticancer properties. It is synthesized by reacting the 3'-hydroxyl group of cytidine with 2,4,6-trimethoxybenzoyl chloride to form N4-(2',6'-dimethoxyphenyl)benzoylcytidine. This compound is then reacted with methylene bis(diethylamino)thiophene (2') and the 5' phosphoramidite of 5'-O-DMT-(2'-O, 4'-C-methylene)-5-methylcytidine. The product is an active synthetic nucleoside that can be used as a building block for other nucleosides or oligonucleotides.

2'-Deoxy-5-propargyloxyuridine is a synthetic compound that inhibits the herpes simplex virus by inhibiting thymidylate synthase, an enzyme in the synthesis of DNA. It is used to study the growth rate of herpes virus and has been shown to inhibit murine leukemia L1210 and human l1210 cells at concentrations of 10-20 μg/mL. 2'-Deoxy-5-propargyloxyuridine has also been shown to have inhibitory activities against other viruses, such as polio virus and influenza virus. 2'-Deoxy-5-propargyloxyuridine inhibits biosynthesis by binding to enzymes involved in the synthesis of nucleic acids. The inhibitory dose for this compound is not yet known, but it has been shown to have an inhibitory effect on cell culture when preincubated with cells before infection with herpes simplex virus.

5-Azacytidine 5'-monophosphate (5-Aza-CMP) is a modified nucleoside that inhibits DNA synthesis by competitively inhibiting the incorporation of deoxycytidine 5'-triphosphate into DNA. It is used as an antiviral and anticancer agent. 5-Aza-CMP has been shown to inhibit the proliferation of human cancer cells in vitro, including T cell leukemia, lymphoma, breast cancer, and melanoma.

8-Fluoroadenosine is a nucleoside that is structurally related to adenosine. It inhibits the activity of adenosinase, an enzyme that breaks down adenosine and other nucleosides. 8-Fluoroadenosine has a pH optimum of 7.8, which is close to the pH of mammalian cells. This compound does not inhibit the action of nucleases, which may be due to its low reactivity with DNA and RNA. 8-Fluoroadenosine has been shown to have an inhibitory effect on cellular proliferation in culture at concentrations of 10 micromolar or higher.

gamma-(BBT)-GTP is a synthetic nucleoside phosphoramidite that is used in the synthesis of DNA and RNA. It has antiviral properties and can be used as an activator of DNA polymerase in the deoxyribonucleotide synthesis. This chemical is novel because it can be modified to contain a phosphate group at the 2'-position, which is not found in natural nucleosides or nucleotides. gamma-(BBT)-GTP is a high-purity chemical that can be synthesized using CAS No. 72335-45-2.

2'-Bromo-2'-deoxy-3'-O-methanesulfonyluridine is a nucleoside analogue that acts as an activator of the human immunodeficiency virus (HIV). It is thought to work by binding to the viral reverse transcriptase enzyme, which converts the RNA genome into DNA. This prevents the virus from replicating and producing new viruses. 2'-Bromo-2'-deoxy-3'-O-methanesulfonyluridine has also been shown to be active against other viruses such as herpes simplex virus type 1 (HSV1) and influenza A virus.

N4-Benzoyl-2'-deoxy-a-cytidine is a novel, modified nucleoside that has shown anticancer and antiviral activity. It is synthesized by the enzymatic oxidation of 2'-deoxyadenosine with benzoyl chloride and sodium bicarbonate. N4-Benzoyl-2'-deoxy-a-cytidine has been shown to activate transcription, increase DNA synthesis, and inhibit virus replication. It also inhibits bacterial growth, but does not appear to have any effect on mammalian cells.

N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-cytidine 3-CE phosphoramidite is a novel nucleoside phosphoramidite that is used for the synthesis of DNA and RNA. It has anticancer properties and has been shown to inhibit the replication of HIV and herpes virus. N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-cytidine 3-CE phosphoramidite is also a potent antiviral that inhibits the production of diphosphate by inhibiting ribonucleotide reductase, an enzyme involved in DNA synthesis.

b-Nicotinamide mononucleotide, or NMN, is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme found in all living cells that is essential for various metabolic processes. NAD+ is involved in critical functions such as DNA repair, gene expression, and cellular stress responses.

3'-Amino-2',3'-dideoxy-2-fluoroadenosine is a novel compound that inhibits the enzyme ribonucleotide reductase, which is involved in the synthesis of DNA. It also has antiviral and anticancer activities. 3'-Amino-2',3'-dideoxy-2-fluoroadenosine has high purity and high quality and can be used as an activator for phosphoramidite synthesis.

5-Bromo-2-methylsulfanyl-pyrimidine-4-carboxylic acid is a pyrimidine derivative that inhibits protein kinases. The compound has been shown to inhibit the activity of protein kinase C, which is involved in mediating inflammatory responses, and phosphorylation of the insulin receptor substrate 1. 5-Bromo-2-methylsulfanyl-pyrimidine-4-carboxylic acid is an efficient inhibitor of kinases and can be used as a lead compound for the development of new compounds with therapeutic potential.

b-Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium), or NADPH, is involved in redox reactions, where it acts as an electron donor. NADPH is essential for anabolic reactions, such as lipid and cholesterol biosynthesis, and fatty acid chain elongation. It also plays a significant role in antioxidation mechanisms, protecting cells from oxidative stress by neutralizing reactive oxygen species (ROS) and regenerating antioxidants like glutathione

P2Y receptor agonist; precursor in RNA biosynthesisÂ

Cis-2'-O-methylcytidine is a modified nucleoside that has shown antiviral and anticancer activity. It is a monophosphate analog of cytidine with high antiviral activity against HIV, HSV-1, HSV-2, EBV, and CMV. Cis-2'-O-methylcytidine also inhibits tumor growth in mice by inhibiting the synthesis of DNA. Cis-2'-O-methylcytidine has been synthesized from ribonucleosides and deoxyribonucleosides to provide high purity and quality.

1-(2-C-Methyl-b-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide is a modified nucleoside that is used as an antiviral and anticancer agent. It is a diphosphate derivative of 1-(2'-deoxyribofuranosyl)-1H-1,2,4-triazole. The compound has been shown to have antiviral activity against herpes simplex virus (HSV) type I and HSV type II in vitro. It also inhibits the growth of human tumor cells in culture by interfering with DNA synthesis. The compound has been reported to be active against leukemia cells in vivo but not against normal cells. It has a high level of toxicity at high doses.

N6-Benzoyl-2'-deoxy-5'-O-DMT-adenosine 3'-thiophosphoramidite is a modified phosphoramidite that can be used to synthesize DNA oligomers. The nucleoside is an antiviral and antitumor agent. It is also used to inhibit the replication of RNA by inhibiting the activity of DNA polymerase. N6-Benzoyl-2'-deoxy-5'-O-DMT-adenosine 3'-thiophosphoramidite has novel properties that have not been seen in any other nucleosides. This product is for research use only, not for diagnostics or therapeutic purposes.

7-[3,5-Bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl-beta-D-ribofuranosyl]-4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine is a synthetic nucleoside analog that inhibits the growth of viruses. It is phosphorylated to the monophosphate form by cellular enzymes and then converted to diphosphate form by cellular enzymes. This nucleoside analog is active against herpes simplex virus type 1 and 2, human cytomegalovirus, and influenza A virus. 7-[3,5-Bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl--D--ribofuranosyl]-4--chloro--5--methyl--7H--pyrrolo[2,3--d]pyrim

5-(Trimethylstannyl)-2'-deoxyuridine is a nucleoside analogue that is structurally related to thymidine. It has been shown to be cytotoxic in vitro, with high cytotoxicity for human glioma cells. This drug has been detected in vivo using autoradiography and microspectrophotometry, with a maximum uptake in the brain and detectable levels in the kidneys and liver. 5-(Trimethylstannyl)-2'-deoxyuridine is taken up by cells through an energy transfer process. The drug is demercurated from the cell surface by extracellular enzymes, such as sulfatases and phosphatases, converting it into 5-mercapto-2'-deoxyuridine (MdUrd), which can be detected by its UV-absorption characteristics.

N4-Benzoyl-2'-O-tert-butyldimethylsilylcytidine is a nucleoside that is modified by the attachment of an acetyl group at the 2' position. It is used as a component in the synthesis of oligonucleotides and can also be used in antiviral and anticancer applications. N4-Benzoyl-2'-O-tert-butyldimethylsilylcytidine is synthesized by reacting 4,5′-dihydroxybenzoic acid with 4-(dimethylamino)pyridine and diisopropylethylamine to form an intermediate, which reacts with cytosine to produce the desired product. This process requires high purity, which can be achieved through high quality production methods.

5-Methoxyuridine is a nucleoside that is structurally related to uridine. It is an intermediate in the biosynthesis of pyrimidines and is also used as a precursor for other compounds. 5-Methoxyuridine has been shown to inhibit protein synthesis by binding to purine receptors and inhibiting the function of protein kinases. The x-ray crystal structures of 5-methoxyuridine bound to two different p2y receptors have been determined. The analytical chemistry of 5-methoxyuridine is based on UV absorption measurements, which are able to identify hydrogen bonds between the base and the sugar moiety. This drug has been investigated for its potential use in cancer therapy due to its ability to inhibit RNA synthesis, which can lead to cell death by incomplete replication or transcription. 5-Methoxyuridine inhibits messenger RNA (mRNA) production in bacteria by interfering with sequence recognition and binding sites within the ribosome and preventing

Ribavirin triphosphate is the biologically active metabolite of antiviral nucleoside analog ribavirin. In cells, the prodrug ribavirin gets triphosphorylated and in it inhibits viral RNA polymerases, interfering with the synthesis of newly formed RNA.

1-(Arabinofuranosyl)-5-azidomethyluracil (AFAU) is a novel nucleoside that is synthesized by the reaction of 5-azido-1-(2'-deoxyribofuranosyl) uracil with phosphoramidite. The synthesis of this nucleoside has been used as a model for the synthesis of other deoxyribonucleosides. AFAU is an activator of ribonucleotide reductase and has shown activity against DNA and RNA viruses, such as influenza virus, herpes simplex virus type 1, and human immunodeficiency virus type 1.

2'-Deoxy-5-fluorocytidine is a methyltransferase inhibitor that inhibits the activity of DNA methyltransferases. It has been shown to inhibit the activity of DNA methyltransferases in vitro and in vivo, leading to tumor cell death. 2'-Deoxy-5-fluorocytidine has been shown to target intracellular targets, such as histones and ribosomes, which are involved in cancer development. The toxicity of this drug has been studied extensively and it has been shown to have low toxicity in mice. This drug is not toxic for normal cells or animals when administered at high doses.

2,3'-Anhydro-2'-deoxyadenosine is a DNA nucleoside and phosphoramidite monomer that belongs to the group of deoxyribonucleosides. It can be used as an antiviral and anticancer agent. 2,3'-Anhydro-2'-deoxyadenosine has been shown to inhibit viral replication by preventing the synthesis of viral DNA and RNA. The drug also inhibits tumor growth by interfering with cell division. This drug can be used in the preparation of phosphoramidites for the synthesis of oligonucleotides for research purposes.

2'-Deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite is a synthetic nucleoside that has shown anticancer and antiviral properties. It was first synthesized in the early 1990s and it is structurally similar to adenosine monophosphate. The synthesis of this compound starts with 5-iodo-2'-deoxyuridine, which reacts with the 5'-O-dimethoxytrityl group to form 2'-deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite. This nucleoside is then reacted with a phosphate triester to form 2'-deoxy-5'-O-DMT-5-[3-(2,2,2,-trimethylpropanoyl)propyl]thymidylic acid diphosphate.

2'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-(4-isopropylphenoxyacetyl)guanosine 3'-CE phosphoramidite is a nucleoside that was synthesized by the reaction of 2'-O-tert-butyldimethylsilyl-5'-O-dimethoxytritylguanosine 3'-CE with 4-isopropylphenoxyacetic acid. This nucleoside has antiviral and anticancer activities. It has been shown to inhibit the growth of human leukemia cells in culture, and also inhibits the replication of human immunodeficiency virus (HIV).

5-Amino-2’-deoxy-2’-O-methyluridine HCl is a novel nucleoside analog that has been modified with an O-methyl group at the 5′ position of the ribose moiety. This modification inhibits phosphorylation by inhibiting DNA polymerase and thus, preventing DNA synthesis. 5-Amino-2’-deoxy-2’-O-methyluridine HCl has also been shown to inhibit viral replication by inhibiting viral RNA and protein synthesis, while not affecting human RNA and protein synthesis. 5AADMUT is an activator of diphosphate metabolism in cells which may be due to its ability to inhibit enzymes involved in nucleotide metabolism (e.g., adenosine kinase).

Please enquire for more information about 2,6-Dichloro-7-methylpurine including the price, delivery time and more detailed product information at the technical inquiry form on this page

2'-Deoxy-2-methoxyadenosine is a nucleoside that has been isolated from the sponge Spongospora. It is a glycosylated nucleoside that contains a formamidine chromophore and an amino function. The molecule has been synthesized by solid-phase synthesis, which involves the use of phosphoramidite chemistry to attach a series of building blocks onto an oligonucleotide template. 2'-Deoxy-2-methoxyadenosine was found to have thermal stability in phosphate buffer solutions and low reactivity with nucleophiles such as ammonia or methylamine. This nucleoside can be used as a substituent in synthetic organic chemistry and has been shown to inhibit the growth of bacteria such as Clostridium perfringens.

7-Cyano-7-deaza-2'-deoxyadenosine is a nucleoside analog that inhibits the growth of virus by competing with deoxyadenosine for incorporation into DNA and RNA. 7-Cyano-7-deaza-2'-deoxyadenosine also stabilizes dna duplexes and prevents them from breaking down. It has been shown to be effective against herpes simplex virus, which causes painful blisters on the skin or genitals. This drug has been used in clinical trials as an antiviral agent. 7-Cyano-7-deaza-2'-deoxyadenosine is synthesized from 2',3'-didehydrocytidine under the following conditions: a) Dissolve 0.5 g of 2',3'-didehydrocytidine in 5 mL of dry DMF, cool to -78° C, and add 0.5 mL of a solution

5-Bromo-deoxyuridine CPG is a novel nucleoside. The chemical name of this compound is 5-bromo-2'-deoxyuridine (CAS No. 2305-39-4). 5-Bromo-deoxyuridine CPG has been synthesized from diphosphate and phosphoramidite. It is used to produce the monophosphate form, which acts as an antiviral and anticancer agent.

N6-Benzoyl-2'-deoxy-5'-O-DMT adenosine 3'-CE phosphoramidite is a protected adenosine amidite.

2'-O-Methyluridine-5'-triphosphate sodium salt is a nucleoside containing a 2'-O-methyl group at the 5' position. It is a novel antiviral and anticancer agent that can inhibit viral replication and induce cell apoptosis. This drug has been shown to be effective against herpes simplex virus type 1 (HSV1) and Epstein-Barr virus (EBV) in vitro, as well as some tumor cells in vivo. 2'-O-Methyluridine-5'-triphosphate sodium salt has also been shown to have high purity and high quality, with less than 0.01% impurities by HPLC, NMR, and elemental analysis analyses.

2',3',5-Tri-O-acetyl-N1-tritylinosine is a novel nucleoside with antiviral and anticancer activities. It is a modified deoxyribonucleoside, which is synthesized by the acetylation of N1-tritylinosine. It has high purity and high quality.

3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione is a synthetic nucleoside analogue that has been modified by the replacement of the 2' oxygen atom. The phosphoramidite is used to produce 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione in high purity and high quality. This product can be used as an antiviral agent and as an anticancer agent. It has also been shown to inhibit DNA synthesis and RNA synthesis.

2',3'-Dideoxy-3'-fluoro-a-uridine is a synthetic nucleoside analog. This compound is a modified version of uridine. The 2' and 3' hydroxyl groups on the sugar molecule are replaced with hydrogen atoms, and a fluorine atom replaces the hydrogen at the 3' position. This molecule has potential antiviral acitivty and can be used in research applications.

2-Cyanoadenosine is a derivative of adenosine. It is an inhibitor of the enzyme adenosine deaminase, which converts adenosine to inosine. 2-Cyanoadenosine prevents the conversion of ATP to AMP and may be useful for treating neurological disorders. 2-Cyanoadenosine has been shown to have cardiovascular effects, such as increasing the force of contraction and relaxation in isolated rat hearts.

9-(2',3',5'-tri-O-benzoyl-5'-(R)-C-Methyl-b-D-ribofuranosyl)-6-chloropurine is a modified nucleoside that is used as an antiviral and anticancer agent. It also has been shown to have antimalarial properties. 9-(2',3',5'-tri-O-benzoyl-5'-(R)-C-Methyl-b-D-ribofuranosyl)-6-chloropurine inhibits viral replication by inhibiting DNA polymerase and RNA polymerase, which are enzymes that synthesize DNA and RNA, respectively. It also possesses anticancer properties and has been shown to be effective against leukemia cells in vitro.

3'-Amino-2',3'-dideoxycytidine's lack of a 3'-hydroxyl group makes it a chain terminator for DNA polymerase, a key application in Sanger sequencing. Additionally, the 3'-amino group serves as a functional handle for modifying the 3' end of oligonucleotides with various labels or conjugates, expanding their utility in research and diagnostics. The lithium salt ensures better handling and solubility.

5-[(Methylamino)methyl]uridine is a proton-containing analog of uridine. It is an epigenetic modifier that has been shown to have conformational properties that are similar to those of uridine. 5-[(Methylamino)methyl]uridine has been shown to modify the glycosidic bond and ring structures, which are important for its function in protein synthesis. The compound can also be found as a chemical structure in the ribosomal subunit, where it is involved in protein synthesis and translation. 5-[(Methylamino)methyl]uridine has shown potential as a therapeutic agent for cancer treatment due to its ability to inhibit the expression of oncogenes in cells and induce programmed cell death (apoptosis).

9-(2',3',5'-Tri-O-benzyl-b-D-arabinofuranosyl)adenine is a nucleoside that has shown anticancer and antiviral properties. It inhibits replication of DNA and RNA in cells, which may be due to its ability to inhibit the synthesis of deoxyribonucleotides and ribonucleotides. This compound is synthetically produced from 2',3',5'-tri-O-benzyl b-D-arabinofuranosyl chloride and adenine monophosphate (AMP). 9-(2',3',5'-Tri-O-benzyl-b-D-arabinofuranosyl)adenine is also known as arabinoside A.

Please enquire for more information about Chemical phosphorylating reagent (cpr) including the price, delivery time and more detailed product information at the technical inquiry form on this page

N4-Acetyl-2'-O-methylcytidine is a chemical compound that is an analog of cytidine. It has been shown to have the ability to stabilize RNA molecules at high temperatures and has been used in the study of epigenetics and thermophilic organisms. N4-Acetyl-2'-O-methylcytidine is also known as AEMC. This compound can be used for reversed phase high performance liquid chromatography, which separates compounds based on their size and shape. Furiosus is a strain of bacteria that contains this chemical compound in its genome. Furiosus was found to contain this compound in its DNA by using posttranscriptional modification techniques such as high performance liquid chromatography (HPLC) and proton nuclear magnetic resonance (NMR).

2',3'-Dideoxyinosine-5'-monophosphate triethylammonium salt is a synthetic nucleoside that is used to inhibit the production of viral DNA. It inhibits viral replication by competing with natural substrates for incorporation into viral DNA during cellular DNA synthesis. 2',3'-Dideoxyinosine-5'-monophosphate triethylammonium salt also has antiviral and anticancer activity. This product is not for human use, but for research purposes only.

1-(2’-Deoxy-2’-fluoro-arabinofuranosyl)-5-hydroxymethyluracil (also abbreviated as FMAU-OH) is a modified nucleoside analog. It consists of a fluorinated sugar moiety (2’-deoxy-2’-fluoro-arabinofuranose) attached to a uracil base with a hydroxymethyl (-CH₂OH) group at the 5-position. The 2’-fluoro substitution and arabinose sugar configuration can enhance its stability and affect its incorporation into DNA or RNA. It has the potential to be used as an inhibitor of viral polymerases and can be used in research.

Please enquire for more information about 3'-Azido-2'-deoxy-5'-O-DMT-thymidine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Second messenger in intracellular signal transduction

5'-O-Benzoyl-D3-thymidine is a nucleoside that is structurally related to thymidine. It can be synthesized by reacting 5'-O-benzoyl-D3-cytosine with thymidine 3',5'-cyclic monophosphate (CMP) and sodium bicarbonate in the presence of riboflavin as an oxidant. The synthesis of 5'-O-benzoyl-D3-thymidine has been shown to be an effective antiviral agent against herpes simplex virus type 1, which has been modified with phenylboronic acid. The anticancer activity of 5'-O-benzoyl-D3-thymidine has also been explored, showing that it inhibits the growth of tumors in mice.

3'-Deoxy-N-dimethylformamidine-5'-O-DMT-guanosine-2'-O-succinoyl-long chain alkylamino-CPG is an anticancer, antiviral, and modified nucleoside. It is a novel monophosphate nucleoside that can be used in the synthesis of DNA or RNA. 3'-Deoxy-N-dimethylformamidine is a synthetic phosphoramidite that is activated with triethylamine and reacts with 5'--DMT--guanosine to yield a novel nucleoside. The compound has high purity and high quality.

2',3',5'-Tri-O-acetyl-8-bromoguanosine is a synthetic nucleoside analog that inhibits the growth of tumor cells. It has been shown to inhibit the progression of prostate cancer and cervical cancer by binding to guanosine, preventing its conversion into ATP. This compound also prevents proliferation in hek293 and glioblastoma cells. The mechanism of action may be due to oxidative phosphite formation, which causes DNA damage and subsequent apoptosis.

monophosphate of 2-deoxy-5-hydroxymethyluridine

3'-Azido-5'-O-tert-butyldimethylsilyl-2',3'-dideoxyuridine is a nucleoside and nucleotide analog. It is an antiviral agent that inhibits the synthesis of viral DNA by inhibiting the activity of DNA polymerase and reverse transcriptase. 3'-Azido-5'-O-tert-butyldimethylsilyl-2',3'-dideoxyuridine has also been shown to have anticancer properties in vitro, but its effectiveness and toxicity have not been studied in vivo.

5'-O-DMT-2'-O-methyluridine (5'-OMeT) is a phosphoramidite building block  of a modified nucleoside that is used in biological research. The stability of 5'-OMeT has been studied by thermal denaturation studies and found to be more stable than other analogues such as 6-azacytidine, 6-azauridine, and 6-azathymidine. This may be due to its increased resistance to endonucleolytic cleavage. 5'-OMeT has not shown any significant biological activity in vivo or in vitro.

4,6-Diamino-2-(b-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine is a nucleoside monophosphate that is used as an antiviral agent. It inhibits the synthesis of viral DNA and RNA by inhibiting the activity of enzymes needed for nucleotide synthesis. 4,6-Diamino-2-(b-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine has shown anticancer properties in vitro against human colon cancer cells. This drug has been shown to inhibit the growth of tumor cells with high expression levels of cyclin D1 and low levels of p27 (a cell cycle regulatory protein).

O2-3'-anhydro-beta-D-fructofuranosyluracil is a novel nucleoside analogue that has antiviral and anticancer properties. It is synthesized by the reaction of beta-D-fructofuranosyluracil with phosphoramidites. The product is purified by HPLC and characterized by IR spectroscopy, UV spectroscopy, and mass spectrometry.

2’-O-Methy-2,5’-anhydro-5-methyluridine is a modified nucleoside with antiviral and anticancer properties. It is an activator of the antiviral response and has been shown to inhibit cancer cells from dividing. This compound is synthesized in an enzymatic reaction that converts 5-methyluridine to 2'-O-methylated uridine. The synthesis involves ribonucleotide reductase, which converts ribonucleotides into deoxyribonucleotides. 2' -O -Methy -2,5'-anhydro-5-methyluridine was originally identified as a novel monophosphate derivative in the 1960s and has been shown to be more effective than other nucleoside analogues.

5'-O-DMT-N4-benzoyl-5-methyl-(2'-O-4'-C-methylene)-cytidine 3'-CE phosphoramidite is a novel nucleoside analogue that has antiviral, anticancer and antimalarial activity. It is also used as a building block for the synthesis of oligonucleotides and in the modification of DNA, RNA and proteins. 5'-O-DMT-N4-benzoyl-5-methyl-(2'-O-4'-C-methylene)-cytidine 3'-CE phosphoramidite is an analogue of cytidine, which can be incorporated into DNA by means of enzymatic reactions. In addition to its antiviral, anticancer and antimalarial properties, it has been shown to have antiinflammatory effects. This drug is synthesized by chemical modification of cytosine, with 2′-, 4′-, or 6′ -

2-tert-Butylpyrimidine-5-carbaldehyde (2BP) is a potent, selective inhibitor of DNA polymerase that is expressed in the tibia during bone development. 2BP has been shown to inhibit platelet-derived growth factor (PDGF)-induced angiogenesis in mouse calvaria and animal research models. This compound also inhibits the proliferation of basic fibroblasts and cancer cells in vitro.

Uridine-3',5'-cyclic monophosphate sodium salt is a phosphotriester that is an intermediate in the biosynthesis of nucleosides. It is also a phosphodiesterase inhibitor, which means it inhibits the breakdown of cyclic nucleotides and allows them to accumulate. This drug has been shown to increase platelet production and has anti-inflammatory effects. Uridine-3',5'-cyclic monophosphate sodium salt is a human metabolite that can be synthesized from uridine, which is present in DNA, RNA, and food sources such as meat, eggs, and milk. The synthesis of uridine-3',5'-cyclic monophosphate sodium salt requires phosphoramidite as a precursor.

5-O-DMT-thymidine 3'-H phosphonate triethylammonium is a novel nucleoside analogue with anticancer activity. The monophosphate form of 5-O-DMT-thymidine 3'-H phosphonate triethylammonium is an activator of DNA, RNA, and protein synthesis in vitro. 5-O-DMT-thymidine 3'-H phosphonate triethylammonium has been shown to be active against herpes simplex virus type 1 and 2 and HIV type 1 in vitro.

5-Bromo-2'-O-tert-butylbutyldimethylsilyl-5'-O-DMT-uridine 3'-CE phosphoramidite is a novel phosphoramidite that can be used in the synthesis of ribonucleosides. Ribonucleoside are modified nucleosides that are important for the production of RNA. This synthetic phosphoramidite has antiviral and anticancer activities, as well as other properties. It is also useful for the production of deoxyribonucleosides, which are necessary for DNA synthesis and repair. 5-Bromo-2'-O-tert-butylbutyldimethylsilyl-5'-O-DMT-uridine 3'-CE phosphoramidite is a high purity, high quality compound that can be used to synthesize nucleic acids.

5’(R)-C-Methyl-5-fluorouridine is a nucleoside that has been shown to activate both ribonucleosides and deoxyribonucleosides. 5’(R)-C-Methyl-5-fluorouridine is a novel nucleotide with the potential to be used in anticancer therapy. It can be used as a building block for DNA synthesis, as well as being able to act as an anticancer drug by inhibiting the growth of cancer cells. This product is made from high quality raw materials and has a purity of at least 98%. It is available in powder form.

2'-Deoxy-2',2'-difluorocytidine 5'-monophosphate triethylammonium salt is an antiviral nucleotide that inhibits the synthesis of viral DNA by competing with natural substrates. It has been shown to be a potent activator of the phosphoramidite method, which is a synthetic method for the production of oligonucleotides. This nucleotide is synthesized by reacting 2-deoxy-2',2'-difluorocytidine 5'-triphosphate with TEA in DMF. The CAS number for this compound is 62533-81-7 and it has a molecular weight of 298.3 Da.

5-Azido-2'-deoxyuridine is a diazonium salt that inhibits the replication of DNA. This compound is synthesized using natural compounds, including 5-azidouracil and formamide. The structure of this compound has been shown to be chromatographically similar to uridine and binds to DNA in vitro. It also has been shown to have biological properties that inhibit the growth of trichomonas vaginalis and dna replication. 5-Azido-2'-deoxyuridine is not very stable in dimethylformamide but can be stored at −20°C for up to two years.

5'-O-Isobutyryl-2',3'-O-isopropylidene-N4-triazolylcytidine (IBITC) is a novel antiviral agent. IBITC is a diphosphate derivative of cytidine with antiviral activity against herpes simplex virus type 1 (HSV1). It has been shown to inhibit HSV1 replication in vitro and in vivo. IBITC is currently undergoing Phase I clinical trials for the treatment of HSV1.

Nelarabine is a drug that prevents the growth of cells by inhibiting the bcr-abl kinase, which is an intracellular target. This drug has been shown to be effective against pediatric patients with t-cell acute lymphoblastic leukemia and adults with chronic myeloid leukemia. Nelarabine has minimal toxicity in humans and is not toxic to healthy cells. It has been shown to have anti-inflammatory properties and may be used as a biomarker for autoimmune diseases. Nelarabine also inhibits angiogenesis, which may be due to its effects on nuclear DNA.

1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)-5-methyluracil is a nucleoside analog for research applications. It contains a β-D-arabinofuranose sugar and the fluorine (F) substitution at the 2'-position enhances stability and improves resistance to enzymatic degradation. The 5-methyluracil base makes it structurally similar to thymidine, allowing it to be recognized by DNA polymerases and kinases.

Coenzyme and regenerating electron donor in catabolic processes

2'-Deoxy-2'-fluoroguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is an antiviral agent of the deoxyribonucleoside family. It is a novel antiviral agent that inhibits viral replication by inhibiting viral DNA synthesis, and it also has anticancer activities. 2'-Deoxy-2'-fluoroguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is modified from guanosine monophosphate (GMP), which is a nucleotide precursor in DNA synthesis, and can be used as an activator for phosphoramidites in the synthesis of DNA.

2'-13CUridine is a nucleoside that is a pyrimidine nucleoside. It is a structural analogue of cytidine and deamination. 2'-13CUridine has been used in the synthesis of anti-cancer drugs such as cytarabine and 5-flurouracil. Cytarabine, a purine analog, is an important component of chemotherapy for the treatment of leukemia, lymphoma, and other cancers.

3’-b-C-Methyladenosine is a novel antiviral and anticancer agent that is synthetically derived from deoxyribonucleosides. 3’-b-C-Methyladenosine has been shown to have antiviral activity against HIV, influenza, herpes simplex virus type 1 and type 2, and vaccinia virus. It also has anticancer activity against leukemia cells. 3’-b-C-Methyladenosine can be used as a phosphoramidite in the synthesis of oligonucleotides. It may be useful as an activator for nucleophilic substitution reactions with phosphorus halides.

Acetyl-coenzyme A is an important intermediate in the metabolism of carbohydrates, fats, and proteins. It is a cytosolic molecule that is synthesized from Acetyl-CoA and ATP. The Michaelis-Menten kinetics describe the relationship between the concentration of acetyl-coenzyme A and the rate of its consumption. Acetyl co-enzyme A is found in many different tissues, including plants, animals, and humans. It has an important role in regulating cellular growth and differentiation by activating various enzymes involved in metabolic pathways. Acetyl CoA can be acetylated to form acetyl CoA carboxylic acid (ACC) which then turns into malonyl CoA through a series of reactions. Malonyl CoA then enters the Krebs cycle as a key intermediate for generating energy from fatty acids.

5-O-Tritylinosine is a modified nucleoside that has shown anticancer and antiviral properties. It is the monophosphate ester of 5-methyluracil and has been shown to inhibit DNA synthesis in vitro. 5-O-Tritylinosine has also been shown to inhibit the replication of herpes simplex virus type 1, which may be due to its ability to inhibit viral DNA polymerase.

2'-Deoxy-2'-fluoroadenosine 5'-a-thiotriphosphate sodium salt (2'F-ATP) is a nucleoside analog that inhibits viral DNA polymerase and induces apoptosis in cancer cells. It is a novel, modified nucleotide that can be phosphorylated to 2'F-dATP, 2'F-AMP, or 2'F-GMP. The phosphate group in 2'F-ATP is replaced by a thiophosphate group, which increases the stability of the molecule and prevents it from being hydrolyzed by phosphatases. This makes it an effective activator for DNA synthesis reactions.

8-Allyloxy-N2-isobutyryl-2-deoxyguanosine is an anticancer drug that has been modified to be resistant to degradation by nucleases. It is a novel deoxyribonucleoside that can be converted into DNA monophosphate and phosphoramidites. 8-Allyloxy-N2-isobutyryl-2-deoxyguanosine is able to inhibit the synthesis of viral RNA and diphosphate, as well as the production of ribonucleosides and diphosphate. It also has antiviral properties, inhibiting the production of HIV RNA and HIV protein synthesis.

5’-Amino-5’-deoxy-2’-O-methyl-5-methyluridine is a novel diphosphate nucleoside analogue of 5'-deoxyribonucleosides. It is a phosphoramidite monophosphate, which is an activator of deoxyribonucleosides. It exhibits antiviral activity against herpes simplex virus type 1 (HSV) and influenza A virus in vitro. It also has anticancer activity against human leukemia cells in vitro. 5'-Amino-5'-deoxy-2' -O methyl -5 methyluridine is supplied in high purity and high quality with a CAS number of 251296-69-2.

5'-O-Acetyl-2',3'-dideoxyinosine is a nucleoside analogue that inhibits viral replication. It is a potent activator of the immune system and has been shown to be effective against cancer cells. 5'-O-Acetyl-2',3'-dideoxyinosine was originally synthesized as an antiviral agent, but it was found to be ineffective in this function. The drug binds to the ribonucleotide reductase enzyme, which converts ribonucleotides into deoxyribonucleotides and is essential for the production of DNA. The drug blocks the conversion of ribonucleotides into deoxyribonucleotides, preventing DNA synthesis and replication. This drug has also been shown to have anticancer activity by inhibiting DNA synthesis and cell division.

5'-O-tert-Butyldimethylsilylthymidine 3'-CE phosphoramidite is a nucleoside which is an activator for DNA synthesis. It is synthesized from the natural substance thymidine, and it can be modified to have various properties by changing the chemical group that attaches to the 3' carbon. 5'-O-tert-Butyldimethylsilylthymidine 3'-CE phosphoramidite is a novel nucleoside that has been shown to be anticancerous in vitro. This compound may also play a role in treating viral infections due to its antiviral properties.

6-(2-Pyridylmethylthio)-9-(b-D-ribofuranosyl)purine is a nucleoside that has antiviral activity and is a potent activator of the immune system. It also has anticancer effects, which may be due to its ability to inhibit DNA synthesis. This nucleoside is synthesized from 2-pyridylethyl methyl sulfide and b-D-ribofuranose. 6-(2-Pyridylmethylthio)-9-(b-D-ribofuranosyl)purine is novel because it contains a modified sugar moiety, phosphoramidites, and monophosphate groups. This product has high purity and quality because it's been purified through high performance liquid chromatography (HPLC).

2'-Azido-2'-deoxyguanosine is an analog of guanine that is used as a fluorescent probe in biochemical and chemical biology studies. It can be synthesized using the azide method, which involves coupling an azide functional group to an aromatic ring. 2'-Azido-2'-deoxyguanosine can also be modified by a number of modifications, including attachment of fluorescent molecules or biotin for labeling purposes. The chemical structure of this compound has been shown to have a conformation that is similar to that of natural guanosine and uridine. 2'-Azido-2'-deoxyguanosine can be detected by proton nuclear magnetic resonance spectroscopy at about 3 ppm, which corresponds to its chemical shift in the range of 200-300 Hz. This compound also has biochemical properties that are similar to those observed for natural guanine and uridine.

3'-O-tert-Butyldimethylsilyl-5'-O-DMT-adenosine is a nucleoside that is used in the synthesis of oligonucleotides. It is a modified nucleoside that can be used as an antiviral or anticancer agent. It has been shown to have high purity and quality. The synthesis of this compound involves the use of a novel activator, which is also available for purchase from this website. This nucleoside has been modified with tert-butyldimethylsilyl groups at the 3' and 5' positions of the ribose moiety, which prevents the hydrolysis of the phosphate ester bond by alkaline phosphatase enzymes, thus allowing for sequence determination.

6-Benzyloxypurine is a fluorescent compound that can be used to measure the concentration of aqueous solutions. It is used in molecular modeling and as a tracer in bioassays. The binding constants for 6-benzyloxypurine have been determined by fluorescence spectrometry, and it has been shown to inhibit the growth of aerobacter aerogenes at concentrations greater than 0.5 mM. This inhibitor also has an inhibitory effect on the growth of tissue culture cells and wastewater treatment bacteria, such as enterococcus faecalis and pseudomonas aeruginosa. The optimum concentration of 6-benzyloxypurine to inhibit bacterial growth is 1 mM, which corresponds to a pH of ~8.2.

UDP-β-L-Arabinofuranose is a research tool used in cell biology and pharmacology. It is an activator of ligand binding to receptor, and it binds with high affinity to the ion channels that regulate the flow of ions across the cell membrane. This compound is a ligand for the protein receptor and can be used as an inhibitor for peptide synthesis. UDP-β-L-Arabinofuranose is a high purity product with CAS No. 331001-44-6 and has been shown to inhibit protein interactions in life science experiments.

Ribonuclesides are a class of modified nucleosides that have been shown to be effective against cancer cells. Oleoyl CoA potassium salt is a Ribonucleoside that inhibits the growth of cancer cells by inhibiting DNA synthesis and RNA synthesis. The Ribonucleosides inhibit the formation of DNA by preventing the conversion of ribose-5-phosphate to deoxyribose-5-phosphate, which is required for DNA synthesis. Oleoyl CoA potassium salt also binds to the enzyme ribonucleotide reductase, which converts ribonucleotides into deoxyribonucleotides, thereby inhibiting DNA synthesis. This drug has been studied in preclinical animal trials.

6-Chloro-7-deaza-9-(a-D-ribofuranosyl)purine is an anticancer drug that belongs to the class of nucleosides. It inhibits DNA and RNA synthesis by blocking the incorporation of nucleotides into DNA or RNA. This drug may also inhibit viral replication by blocking viral polymerase activity. 6-Chloro-7-deaza-9-(a-D-ribofuranosyl)purine has been shown to be a potent activator of phosphoramidites, which are used in chemical synthesis. This novel compound is synthesized using modified diphosphate chemistry and purified to high purity.

2'-Deoxy-N7-methylguanosine is a hydrogenolysis product of guanosine. It can be synthesized in four steps from glycosyl chloride, glycosylamine, and methyl iodide. The catalytic hydrogenolysis of 2'-deoxy-N7-methylguanosine with Raney Ni gives the corresponding 6-amino derivative. Hydrolysis of this amino group converts it to a nucleoside. This nucleoside has been shown to hydrolyze with half-life of about 1 hour at pH 8.5 and 37°C. The hydrolysis of purines by 2'-deoxy-N7-methylguanosine is inhibited by adenosine analogues like 2',3'-dideoxyadenosine and 3',4'-dideoxyadenosine.

4'-Thiothymidine is a nucleoside analog that is used in antiviral therapy against herpes simplex virus. It inhibits the viral DNA polymerase, which prevents the virus from duplicating its genetic material. 4'-Thiothymidine has been shown to inhibit the uptake of 4-thiouracil by cells and to have anti-inflammatory properties. The drug has been found to be effective in inhibiting human adenocarcinoma cell lines in vitro and in vivo.

N6-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-O-(2-methoxyethyl)adenosine is a modified nucleoside with antiviral activity. This compound is synthesized by a modified method that avoids the use of phosphoramidites, which are usually used to synthesize nucleosides. N6-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-O-(2-methoxyethyl)adenosine is an activator of viral RNA polymerase and has been shown to be active against HIV and herpes simplex virus type 1.

N2-Phenoxyacetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)guanosine is an anticancer nucleoside with antiviral and antimalarial activities. This compound has been shown to inhibit the growth of human leukemia cells in vitro and has a pharmacokinetic profile suitable for use in humans. N2-Phenoxyacetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)guanosine is a novel nucleotide analog with high purity and quality.

2'-O-(tert-Butyldimethylsilyl)-3'-O-(phenoxythioncarbonyl)-5'-O-trityluridine (TBS-PTU) is a modified nucleoside that has antiviral activity. TBS-PTU inhibits viral replication by interfering with the synthesis of viral RNA and DNA. The antiviral activity of TBS-PTU is increased in the presence of ribonucleotide reductase, an enzyme that converts ribonucleotides to deoxyribonucleotides. TBS-PTU is used as a building block for DNA synthesis and as a precursor to other modified nucleosides.

4-Thiothymidine is a nucleoside analog that is converted to thymidine by the enzyme thymidine kinase. It has been shown to inhibit the growth of human skin cancer cells by binding to DNA duplexes and inhibiting the synthesis of new DNA strands. 4-Thiothymidine has also been shown to be effective against radiation-induced damage in cultured human cells and inhibits tumor growth in mice bearing a transplantable mouse skin cancer. 4-Thiothymidine can be used as an inhibitor for chemotherapy or radiation therapy for cancer patients. It is active on both site-specific and cell-specific gene targets, with a reactive hydrogen bond that helps stabilize its formation.

5'-O-Benzyl-D3-thymidine 3'-CE phosphoramidite is a novel 5'-O-benzyl modified nucleoside. It has antiviral, anticancer and monophosphate properties. It is also an activator of the diphosphate moiety and has been used in DNA synthesis and in the preparation of oligonucleotides. This compound has been shown to be an efficient inhibitor of HIV reverse transcriptase and human T cell leukemia virus type 1 (HTLV-1) replication. 5'-O-Benzyl-D3-thymidine 3'-CE phosphoramidite is an analogue of thymidine 3'-CMP that has been synthesized with a benzyl group on the 5' position.

8-(4-Chlorophenylthio)-2'-O-methyladenosine 3',5'-cyclic monophosphate sodium salt (8-CPT-cAMP) is a cyclic nucleotide that activates adenyl cyclase, which increases intracellular levels of the second messenger cAMP. It also inhibits P2Y receptors and other ion channels. 8-CPT-cAMP has been shown to be effective in activating cells expressing the enzyme camp levels, such as those found in heart muscle cells. This drug is used clinically to lower blood pressure, as it has been shown to activate amp-activated protein kinase and calcium chelator. 8-CPT-cAMP may have clinical applications for the treatment of cancer due to its ability to induce cell cycle arrest and apoptosis.

Please enquire for more information about 2'-Deoxyadenosine-15N1 N-oxide including the price, delivery time and more detailed product information at the technical inquiry form on this page

5'-O-Benzyl-2'-deoxy-N6-DMF-adenosine 3'-CE phosphoramidite is a novel monophosphate nucleoside that is synthesized by the coupling of 5'-O-benzyl-2'-deoxyadenosine 3'-CE and 2,4,6-trichlorobenzoyl chloride. The product is used as a precursor in the synthesis of various nucleosides and nucleotides. It has antiviral activity against HIV and HSV1. 5'-O-Benzyl-2'-deoxyadenosine 3'-CE phosphoramidite has been shown to be effective against Methicillin resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although it is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex.

2'-Azido-2'-deoxyguanosine-5'-triphosphate lithium salt is a chemically modified nucleotide analog in which the 2'-hydroxyl group of guanosine is replaced by an azido group, and the molecule is phosphorylated at the 5' position with a triphosphate moiety, forming a lithium salt for stability and solubility. This molecule has potential in research applications